Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CHEK
CHEK logo

CHEK Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
11.46M
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
11.04M
EV/OCF(TTM)
--
P/S(TTM)
--
Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
Show More

Events Timeline

(ET)
2025-09-12
17:46:33
Check-Cap and MBody AI Reach Merger Agreement
select
2025-06-04 (ET)
2025-06-04
07:07:22
Check-Cap 'publicly condemned' MediPharm Labs, Chairman Chris Taves
select
2025-05-23 (ET)
2025-05-23
13:04:17
Medipharm Labs provides information on three Apollo Capital nominees
select

News

TipRanks
2.0
2025-09-16TipRanks
3 Penny Stocks to Keep an Eye on This Week, 9/16/25
  • Penny Stocks to Watch: AtlasClear Holdings, Check-Cap Ltd., and aTyr Pharma are highlighted as top penny stocks to monitor on September 16, 2025, based on their high Dollar Volume and significant stock price movements.

  • AtlasClear Holdings (ATCH): The company experienced a 153% stock price increase and a Dollar Volume of $493.14 million after reporting a substantial rise in net income and introducing a new broker-dealer.

  • Check-Cap Ltd. (CHEK): CHEK's stock surged by 184% with a Dollar Volume of $274.77 million following the announcement of a merger with AI company MBody AI, pending shareholder approval.

  • aTyr Pharma (ATYR): Despite a significant drop of over 83% in stock price and a Dollar Volume of $157.38 million, aTyr Pharma plans to discuss its Phase 3 clinical trial results with the FDA, believing in the potential of its treatment for pulmonary sarcoidosis.

Benzinga
4.5
2025-09-15Benzinga
Crude Oil Increases by 1%; New York's Manufacturing Activity Declines in September
  • U.S. Stock Market Performance: U.S. stocks saw gains with the Dow Jones up 0.1%, NASDAQ rising 0.75%, and S&P 500 increasing by 0.37%. Consumer discretionary shares led the rise, while health care stocks fell by 0.5%.

  • Significant Stock Movements: Check-Cap Ltd. shares surged 261% following a merger announcement, while Helius Medical Technologies saw a 161% increase after launching a treasury strategy. Conversely, aTyr Pharma's shares plummeted 81% due to disappointing study results.

  • Commodity Prices: Oil prices increased by 1% to $63.31, while gold rose 0.3%. Silver saw a slight decline of 0.1%, and copper prices increased by 1%.

  • International Market Trends: European shares mostly rose, with the eurozone's STOXX 600 up 0.47%. Asian markets were mixed, with Hong Kong's Hang Seng gaining slightly, while China's Shanghai Composite and India's BSE Sensex experienced minor declines.

Benzinga
4.5
2025-09-15Benzinga
Nasdaq Rises by More Than 100 Points; Tesla Stock Soars
  • U.S. Stock Market Performance: U.S. stocks opened higher, with the Nasdaq Composite gaining over 100 points, while the Dow and S&P 500 also saw increases of 0.19% and 0.47%, respectively. Communication services stocks rose by 1.7%, but consumer staples fell by 0.6%.

  • Tesla's Share Purchase: Tesla shares rose approximately 6% after CEO Elon Musk purchased 2.57 million shares, increasing his indirect ownership to about 413 million shares.

  • Notable Stock Movements: Check-Cap Ltd. shares surged 233% following a merger announcement, while Helius Medical Technologies saw a 179% increase after launching a treasury strategy. Conversely, aTyr Pharma's shares plummeted 82% after disappointing clinical trial results.

  • Global Market Trends: European shares rose, with the eurozone's STOXX 600 up 0.6%, while Asian markets were mixed. The New York Empire State Manufacturing Index fell to -8.7 in September, indicating a decline in manufacturing activity.

TipRanks
8.5
2025-09-15TipRanks
M&A Update: Check-Cap (CHEK) Shares Surge Following MBody AI Merger Announcement
  • Merger Announcement: Check-Cap (CHEK) stock surged after announcing a merger with MBody AI, which will focus on embodied AI for the autonomous workforce, with MBody AI investors holding 90% of the new entity.

  • Market Potential and Focus: MBody AI aims to dominate the embodied AI market, projected to reach $40 trillion by 2050, initially targeting the hospitality sector while planning to expand into warehousing, office management, and healthcare.

Benzinga
4.5
2025-09-15Benzinga
Stock Market Update: S&P 500 Futures Increase, Nasdaq Declines in Varied Trading—Focus on Nvidia, Hain Celestial, and Check Cap
  • Market Overview: U.S. stock futures showed mixed movements following a mixed close on Friday, with major indices like the Dow Jones and S&P 500 experiencing slight declines while the Nasdaq Composite gained. Investors are closely watching the Federal Reserve's upcoming interest rate decision.

  • Investor Sentiment: Despite recent gains in major equity benchmarks, individual investor sentiment has turned increasingly bearish, with 49.5% expressing negative outlooks for the stock market's six-month performance, the highest level of pessimism since May.

  • Economic Indicators: Key economic data releases are scheduled for the week, including manufacturing surveys, retail sales, and the Federal Reserve's interest rate decision, which is anticipated to address concerns over a weakening labor market and potential inflation risks.

  • Stock Highlights: Notable stock movements include Hain Celestial Group surging 20% ahead of its earnings report, while Nvidia dropped 2.46% due to antitrust rulings in China. Other companies like Adobe and IBEX Ltd reported strong earnings, contributing to mixed market reactions.

Benzinga
8.5
2025-09-15Benzinga
Check-Cap Shares Surge 183%; Discover 20 Stocks Making Moves in Premarket Trading
  • Check-Cap Ltd Merger Announcement: Check-Cap Ltd's shares surged 183% in pre-market trading following the announcement of a definitive merger agreement with MBody AI, which Chairman David Lontini described as a strategic move into a high-growth industry.

  • Other Notable Pre-Market Movements: Several stocks experienced significant pre-market trading changes, including Helius Medical Technologies (up 163.2%), InnSuites Hospitality Trust (up 118%), and AtlasClear Holdings (up 69.5%), while ECD Automotive Design and Sidus Space saw declines of 27.2% and 26.3%, respectively.

Valuation Metrics

The current forward P/E ratio for Check Cap Ltd (CHEK.O) is 0.00, compared to its 5-year average forward P/E of -2.88. For a more detailed relative valuation and DCF analysis to assess Check Cap Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-2.88
Current PE
0.00
Overvalued PE
-0.73
Undervalued PE
-5.03

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.01
Overvalued PS
0.01
Undervalued PS
-0.00

Financials

AI Analysis
Annual
Quarterly

Whales Holding CHEK

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Check Cap Ltd (CHEK) stock price today?

The current price of CHEK is 0 USD — it has increased 0

What is Check Cap Ltd (CHEK)'s business?

Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.

What is the price predicton of CHEK Stock?

Wall Street analysts forecast CHEK stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CHEK is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Check Cap Ltd (CHEK)'s revenue for the last quarter?

Check Cap Ltd revenue for the last quarter amounts to -4.08M USD, decreased -3.08

What is Check Cap Ltd (CHEK)'s earnings per share (EPS) for the last quarter?

Check Cap Ltd. EPS for the last quarter amounts to -3539000.00 USD, decreased -16.49

How many employees does Check Cap Ltd (CHEK). have?

Check Cap Ltd (CHEK) has 85 emplpoyees as of March 22 2026.

What is Check Cap Ltd (CHEK) market cap?

Today CHEK has the market capitalization of 11.46M USD.